160 related articles for article (PubMed ID: 23015131)
1. Peptide binding specificities of HLA-B*5701 and B*5801.
Zhang Y; Mei H; Wang Q; Xie J; Lv J; Pan X; Tan W
Sci China Life Sci; 2012 Sep; 55(9):818-25. PubMed ID: 23015131
[TBL] [Abstract][Full Text] [Related]
2. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase.
Chui CK; Brumme ZL; Brumme CJ; Yip B; Phillips EJ; Montaner JS; Harrigan PR
Clin Infect Dis; 2007 Jun; 44(11):1503-8. PubMed ID: 17479950
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
Barber LD; Percival L; Arnett KL; Gumperz JE; Chen L; Parham P
J Immunol; 1997 Feb; 158(4):1660-9. PubMed ID: 9029102
[TBL] [Abstract][Full Text] [Related]
4. The Role of Conformational Dynamics in Abacavir-Induced Hypersensitivity Syndrome.
Fodor J; Riley BT; Kass I; Buckle AM; Borg NA
Sci Rep; 2019 Jul; 9(1):10523. PubMed ID: 31324847
[TBL] [Abstract][Full Text] [Related]
5. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
[TBL] [Abstract][Full Text] [Related]
6. [HLA-B*5701 and abacavir hypersensitivity reaction].
Servonnet A; Leclercq E; Delacour H; Ceppa F
Pathol Biol (Paris); 2010 Dec; 58(6):e95-100. PubMed ID: 19243901
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
Chessman D; Kostenko L; Lethborg T; Purcell AW; Williamson NA; Chen Z; Kjer-Nielsen L; Mifsud NA; Tait BD; Holdsworth R; Almeida CA; Nolan D; Macdonald WA; Archbold JK; Kellerher AD; Marriott D; Mallal S; Bharadwaj M; Rossjohn J; McCluskey J
Immunity; 2008 Jun; 28(6):822-32. PubMed ID: 18549801
[TBL] [Abstract][Full Text] [Related]
8. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.
Griffin TA; Yuan J; Friede T; Stevanovic S; Ariyoshi K; Rowland-Jones SL; Rammensee HG; Colbert RA
J Immunol; 1997 Nov; 159(10):4887-97. PubMed ID: 9366414
[TBL] [Abstract][Full Text] [Related]
9. Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction?
Bracciale L; Santangelo R; Fanti I; Prosperi M; Colafigli M; Di Giambenedetto S; Marchetti S; Di Franco A; Cauda R; De Luca A
Antivir Ther; 2009; 14(1):99-101. PubMed ID: 19320242
[TBL] [Abstract][Full Text] [Related]
10. HLA-B*5701 screening for hypersensitivity to abacavir.
Mallal S; Phillips E; Carosi G; Molina JM; Workman C; Tomazic J; Jägel-Guedes E; Rugina S; Kozyrev O; Cid JF; Hay P; Nolan D; Hughes S; Hughes A; Ryan S; Fitch N; Thorborn D; Benbow A;
N Engl J Med; 2008 Feb; 358(6):568-79. PubMed ID: 18256392
[TBL] [Abstract][Full Text] [Related]
11. Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies.
Sobao Y; Tsuchiya N; Takiguchi M; Tokunaga K
Arthritis Rheum; 1999 Jan; 42(1):175-81. PubMed ID: 9920028
[TBL] [Abstract][Full Text] [Related]
12. Several HLA alleles share overlapping peptide specificities.
Sidney J; del Guercio MF; Southwood S; Engelhard VH; Appella E; Rammensee HG; Falk K; Rötzschke O; Takiguchi M; Kubo RT
J Immunol; 1995 Jan; 154(1):247-59. PubMed ID: 7527812
[TBL] [Abstract][Full Text] [Related]
13. In silico analysis of peptide binding features of HLA-B*4006.
Gadewal NS; Joshi NN
Indian J Exp Biol; 2012 Feb; 50(2):93-100. PubMed ID: 22670471
[TBL] [Abstract][Full Text] [Related]
14. Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience.
Waters LJ; Mandalia S; Gazzard B; Nelson M
AIDS; 2007 Nov; 21(18):2533-4. PubMed ID: 18025891
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta.
Berka N; Gill JM; Liacini A; O'Bryan T; Khan FM
Hum Immunol; 2012 Feb; 73(2):164-7. PubMed ID: 22197535
[TBL] [Abstract][Full Text] [Related]
16. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome.
Martin AM; Krueger R; Almeida CA; Nolan D; Phillips E; Mallal S
Pharmacogenet Genomics; 2006 May; 16(5):353-7. PubMed ID: 16609367
[TBL] [Abstract][Full Text] [Related]
17. Characterization of structure-antioxidant activity relationship of peptides in free radical systems using QSAR models: key sequence positions and their amino acid properties.
Li YW; Li B
J Theor Biol; 2013 Feb; 318():29-43. PubMed ID: 23127747
[TBL] [Abstract][Full Text] [Related]
18. Abacavir hypersensitivity reaction predicted by genetic test.
AIDS Treat News; 2004 Mar; (399):6. PubMed ID: 15199868
[TBL] [Abstract][Full Text] [Related]
19. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
Tian F; Yang L; Lv F; Yang Q; Zhou P
Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
[TBL] [Abstract][Full Text] [Related]
20. Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants.
Bade-Doeding C; DeLuca DS; Seltsam A; Blasczyk R; Eiz-Vesper B
Immunogenetics; 2007 Apr; 59(4):253-9. PubMed ID: 17294180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]